Yuda J - Search Results

1

Subcutaneous epcoritamab monotherapy in Japanese adults with relapsed/refractory diffuse large B-cell lymphoma.

Izutsu K, Kumode T, Yuda J, Nagai H, Mishima Y, Suehiro Y, Yamamoto K, Fujisaki T, Ishitsuka K, Ishizawa K, Ikezoe T, Nishikori M, Akahane D, Fujita J, Dinh M, Soong D, Noguchi H, Buchbjerg JK, Favaro E, Fukuhara N. Izutsu K, et al. Among authors: yuda j. Cancer Sci. 2023 Dec;114(12):4643-4653. doi: 10.1111/cas.15996. Epub 2023 Nov 3. Cancer Sci. 2023. PMID: 37921363 Free PMC article.

2

Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.

Hosono N, Chi S, Yamauchi T, Fukushima K, Shibayama H, Katagiri S, Gotoh A, Eguchi M, Morishita T, Ogasawara R, Kondo T, Yanada M, Yamamoto K, Kobayashi T, Kuroda J, Usuki K, Utsu Y, Yoshimitsu M, Ishitsuka K, Ono T, Takahashi N, Iyama S, Kojima K, Nakamura Y, Fukuhara S, Izutsu K, Abutani H, Yamauchi N, Yuda J, Minami Y; All HM-SCREEN-Japan 01 Investigators. Hosono N, et al. Among authors: yuda j. Cancer Sci. 2023 May;114(5):2098-2108. doi: 10.1111/cas.15746. Epub 2023 Mar 1. Cancer Sci. 2023. PMID: 36793248 Free PMC article.

3

Persistent detection of alternatively spliced BCR-ABL variant results in a failure to achieve deep molecular response.

Yuda J, Miyamoto T, Odawara J, Ohkawa Y, Semba Y, Hayashi M, Miyamura K, Tanimoto M, Yamamoto K, Taniwaki M, Akashi K. Yuda J, et al. Cancer Sci. 2017 Nov;108(11):2204-2212. doi: 10.1111/cas.13353. Epub 2017 Sep 21. Cancer Sci. 2017. PMID: 28801986 Free PMC article.

4

Tyrosine kinase inhibitors induce alternative spliced BCR-ABL^Ins35bp variant via inhibition of RNA polymerase II on genomic BCR-ABL.

Yuda J, Odawara J, Minami M, Muta T, Kohno K, Tanimoto K, Eto T, Shima T, Kikushige Y, Kato K, Takenaka K, Iwasaki H, Minami Y, Ohkawa Y, Akashi K, Miyamoto T. Yuda J, et al. Cancer Sci. 2020 Jul;111(7):2361-2373. doi: 10.1111/cas.14424. Epub 2020 Jun 14. Cancer Sci. 2020. PMID: 32314454 Free PMC article.

5

Asciminib vs bosutinib in CML patients pretreated with ≥2 tyrosine kinase inhibitors: Results from the Japanese subgroup analysis of ASCEMBL study.

Yuda J, Doki N, Matsuoka H, Yokota T, Tomita A, Takahashi N, Matsumura I, Kubo K, Goto T, Kirito K, Maki A, Aoki M, Allepuz A, Minami Y. Yuda J, et al. Cancer Med. 2023 Feb;12(3):2990-2998. doi: 10.1002/cam4.5212. Epub 2022 Sep 27. Cancer Med. 2023. PMID: 36168187 Free PMC article. Clinical Trial.

6

Brentuximab vedotin maintenance after autologous stem cell transplantation for refractory gray zone lymphoma with long-term remission.

Terao T, Yuda J, Yamauchi N, Guo YM, Shimada K, Sugano M, Ishii G, Minami Y. Terao T, et al. Among authors: yuda j. Mol Clin Oncol. 2021 Jun;14(6):125. doi: 10.3892/mco.2021.2287. Epub 2021 Apr 23. Mol Clin Oncol. 2021. PMID: 33936598 Free PMC article.

7

Molecular remission after combination therapy with blinatumomab and ponatinib with relapsed/refractory Philadelphia chromosome-positive acute lymphocytic leukemia: two case reports.

Yuda J, Yamauchi N, Kuzume A, Guo YM, Sato N, Minami Y. Yuda J, et al. J Med Case Rep. 2021 Mar 25;15(1):164. doi: 10.1186/s13256-021-02771-z. J Med Case Rep. 2021. PMID: 33762010 Free PMC article.

8

Emerging Immunotherapy for Acute Myeloid Leukemia.

Tabata R, Chi S, Yuda J, Minami Y. Tabata R, et al. Among authors: yuda j. Int J Mol Sci. 2021 Feb 16;22(4):1944. doi: 10.3390/ijms22041944. Int J Mol Sci. 2021. PMID: 33669431 Free PMC article. Review.

9

[Tyrosine kinase inhibitors induce production of BCR-ABL^Ins35bp splicing variants via inhibition of RNA polymerase II on genomic BCR-ABL and cause unachieved deep molecular response and fluctuating minimal residual disease].

Yuda J. Yuda J. Rinsho Ketsueki. 2022;63(8):880-892. doi: 10.11406/rinketsu.63.880. Rinsho Ketsueki. 2022. PMID: 36058859 Japanese.

10

[Vascular adverse events of ponatinib during treatment of Philadelphia chromosome-positive leukemia: a retrospective single-institution analysis].

Sato N, Yuda J, Yamauchi N, Miyamoto K, Kamihara Y, Minami Y. Sato N, et al. Among authors: yuda j. Rinsho Ketsueki. 2019;60(12):1623-1629. doi: 10.11406/rinketsu.60.1623. Rinsho Ketsueki. 2019. PMID: 31902811 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page